Marques A - Search Results

1

Treatment trials for post-Lyme disease symptoms revisited.

Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Klempner MS, et al. Among authors: marques a. Am J Med. 2013 Aug;126(8):665-9. doi: 10.1016/j.amjmed.2013.02.014. Epub 2013 Jun 10. Am J Med. 2013. PMID: 23764268 Free PMC article. Review.

2

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates.

Bacon RM, Biggerstaff BJ, Schriefer ME, Gilmore RD Jr, Philipp MT, Steere AC, Wormser GP, Marques AR, Johnson BJ. Bacon RM, et al. J Infect Dis. 2003 Apr 15;187(8):1187-99. doi: 10.1086/374395. Epub 2003 Apr 2. J Infect Dis. 2003. PMID: 12695997 Free PMC article.

3

Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, Philipp MT. Fleming RV, et al. Among authors: marques ar. Eur J Clin Microbiol Infect Dis. 2004 Aug;23(8):615-8. doi: 10.1007/s10096-004-1163-z. Epub 2004 Jul 8. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15243815 Clinical Trial.

4

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis.

Philipp MT, Wormser GP, Marques AR, Bittker S, Martin DS, Nowakowski J, Dally LG. Philipp MT, et al. Clin Diagn Lab Immunol. 2005 Sep;12(9):1069-74. doi: 10.1128/CDLI.12.9.1069-1074.2005. Clin Diagn Lab Immunol. 2005. PMID: 16148173 Free PMC article.

5

Chronic Lyme disease: a review.

Marques A. Marques A. Infect Dis Clin North Am. 2008 Jun;22(2):341-60, vii-viii. doi: 10.1016/j.idc.2007.12.011. Infect Dis Clin North Am. 2008. PMID: 18452806 Free PMC article. Review.

6

Re: A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Prolonged Lyme disease treatment: enough is enough.

Marques A, Shaw P, Schmid CH, Steere A, Kaplan RF, Hassett A, Shapiro E, Wormser GP. Marques A, et al. Neurology. 2009 Jan 27;72(4):383-4; author reply 384. doi: 10.1212/01.wnl.0000343855.45704.7c. Neurology. 2009. PMID: 19171842 No abstract available.

7

Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome.

Chandra A, Wormser GP, Marques AR, Latov N, Alaedini A. Chandra A, et al. Among authors: marques ar. Clin Vaccine Immunol. 2011 May;18(5):767-71. doi: 10.1128/CVI.00002-11. Epub 2011 Mar 16. Clin Vaccine Immunol. 2011. PMID: 21411605 Free PMC article.

8

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.

Chandra A, Latov N, Wormser GP, Marques AR, Alaedini A. Chandra A, et al. Among authors: marques ar. Clin Immunol. 2011 Oct;141(1):103-10. doi: 10.1016/j.clim.2011.06.005. Epub 2011 Jul 2. Clin Immunol. 2011. PMID: 21778118 Free PMC article.

9

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS. Wormser GP, et al. Among authors: marques a. Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11. Diagn Microbiol Infect Dis. 2013. PMID: 23062467 Free PMC article.

10

The reply.

Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Klempner MS, et al. Among authors: marques a. Am J Med. 2014 Feb;127(2):e11-2. doi: 10.1016/j.amjmed.2013.09.029. Epub 2013 Oct 15. Am J Med. 2014. PMID: 24462014 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,695 results

Search Page